盐酸马普替林

  • 基本信息
  • 制备方法及用途
  • 物化性质
  • 安全信息
  • 毒理性
  • MSDS
  • 海关数据
  • 结构与计算化学
  • 下游产品

盐酸马普替林 基本信息

中文名称:
盐酸马普替林 
中文别名:
盐酸马普替林;
1-(3-甲基氨基丙基)二苯并[b,e]二环[2.2.2]辛二烯盐酸盐 
英文名称:
Maprotiline hydrochloride
英文别名:
Maprotiline Hydrochloride;
9-(γ-Methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene Hydrochloride;
Maprotiline hydrochloride 
CAS No.:
10347-81-6
分 子 式:

C20H23N.ClH

分 子 量:
313.86
精确分子量:
313.16000
PSA:
12.03000
MDL:
MFCD00079464
EINECS:
233-758-8
InChI:
InChI=1/C20H23N.ClH/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20;/h2-5,7-10,15,21H,6,11-14H2,1H3;1H/t15-,20+;
危险品标志:

HarmfulXn

风险术语:

R22

安全术语:

 

分子结构式:
SDS:
查看

盐酸马普替林 制备方法及用途

制备方法

抗抑郁药,用于内因性、反应性、更年期等各种类型的抑郁性神经症。

用途简介

用途

抗抑郁药,用于内因性、反应性、更年期等各种类型的抑郁性神经症。

盐酸马普替林 物化性质

外观与性状:
白色粉末
熔点:
230-232ºC
沸点:
399.6ºC at 760 mmHg
闪点:
187.7ºC
蒸汽压:
9.8E-08mmHg at 25°C
存储条件/存储方法:

密封于阴凉干燥处。

稳定性相关:

遵照规格使用和储存则不会分解。

其它信息:

1.       性状:白色粉末。

2.       密度(g/mL,25/4℃): 无可用

3.       相对蒸汽密度(g/mL,空气=1): 无可用

4.       熔点(ºC):230-232。

5.       沸点(ºC,常压): 无可用

6.       沸点(ºC,5.2kPa): 无可用

7.       折射率: 无可用

8.       闪点(ºC): 无可用

9.       比旋光度(º): 无可用

10.    自燃点或引燃温度(ºC):无可用

11.    蒸气压(kPa,25ºC):无可用

12.    饱和蒸气压(kPa,60ºC):无可用

13.    燃烧热(KJ/mol):无可用

14.    临界温度(ºC):无可用

15.    临界压力(KPa):无可用

16.    油水(辛醇/水)分配系数的对数值:无可用

17.    爆炸上限(%,V/V):无可用

18.    爆炸下限(%,V/V):无可用

19.    溶解性:能溶于水。

盐酸马普替林 安全信息

包装等级:
III
风险类别:
6.1(b)
海关代码:
2921499090
危险类别码:
R22
危险标志:
Xn:Harmful;

盐酸马普替林 毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
KJ4555000
CHEMICAL NAME :
9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-, hydrochloride
CAS REGISTRY NUMBER :
10347-81-6
LAST UPDATED :
199706
DATA ITEMS CITED :
31
MOLECULAR FORMULA :
C20-H23-N.Cl-H
MOLECULAR WEIGHT :
313.90
WISWESSER LINE NOTATION :
L6 H666/GP 2AF P&&TTJ G3M1 &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Cardiac - arrhythmias (including changes in conduction) Cardiac - pulse rate increase, without fall in BP
REFERENCE :
AJEMEN American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- Volume(issue)/page/year: 2,144,1984
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
7 mg/kg/1W-I
TOXIC EFFECTS :
Behavioral - muscle contraction or spasticity
REFERENCE :
JCPYDR Journal of Clinical Pyschopharmacology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1981- Volume(issue)/page/year: 3,264,1983
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
490 ug/kg
TOXIC EFFECTS :
Behavioral - sleep
REFERENCE :
JCLPDE Journal of Clinical Psychiatry. (Physicians Postgraduate Press, Inc., POB 240008, Memphis, TN 38124) V.39- 1978- Volume(issue)/page/year: 47,210,1986
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human
DOSE/DURATION :
17 mg/kg
TOXIC EFFECTS :
Behavioral - general anesthetic Behavioral - hallucinations, distorted perceptions Behavioral - convulsions or effect on seizure threshold
REFERENCE :
BMJOAE British Medical Journal. (British Medical Assoc., BMA House, Tavistock Sq., London WC1H 9JR, UK) V.1- 1857- Volume(issue)/page/year: 1,1573,1977
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
75 mg/kg
TOXIC EFFECTS :
Behavioral - coma Cardiac - pulse rate increase, without fall in BP
REFERENCE :
ICMED9 Intensive Care Medicine. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.3- 1977- Volume(issue)/page/year: 11,220,1985
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - child
DOSE/DURATION :
12 mg/kg
TOXIC EFFECTS :
Cardiac - pulse rate increase, without fall in BP Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - other changes
REFERENCE :
AJEMEN American Journal of Emergency Medicine. (WB Saunders, Philadelphia, PA) V.1- 1983- Volume(issue)/page/year: 6,247,1988
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
90 mg/kg
TOXIC EFFECTS :
Behavioral - coma
REFERENCE :
JATOD3 Journal of Analytical Toxicology. (Preston Pub. Inc., POB 48312, Niles, IL 60648) V.1- 1977- Volume(issue)/page/year: 6,199,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
760 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
72 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
170 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
35 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - muscle weakness Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 1,207,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
480 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - muscle weakness Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 1,207,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 229,163,1977
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
310 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold Behavioral - muscle weakness Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 1,207,1975
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
31 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,782,1973
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
>300 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
30 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
20 mg/kg
TOXIC EFFECTS :
Peripheral Nerve and Sensation - flaccid paralysis without anesthesia (usually neuromuscular blockage) Behavioral - convulsions or effect on seizure threshold Lungs, Thorax, or Respiration - respiratory depression
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,601,1973 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10950 mg/kg/52W-I
TOXIC EFFECTS :
Related to Chronic Data - death
REFERENCE :
BCFAAI Bollettino Chimico Farmaceutico. (Societa Editoriale Farmaceutica, Via Ausonio 12, 20123 Milan, Italy) V.33- 1894- Volume(issue)/page/year: 112,782,1973
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
2800 mg/kg/28D-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - changes in bladder weight Endocrine - changes in spleen weight Related to Chronic Data - changes in testicular weight
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 1,207,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10920 mg/kg/26W-I
TOXIC EFFECTS :
Liver - fatty liver degeneration Endocrine - changes in spleen weight Related to Chronic Data - changes in prostate weight
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 1,207,1975 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
15 mg/kg
SEX/DURATION :
female 13 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - breasts, lactation (prior to or during pregnancy)
REFERENCE :
AJPSAO American Journal of Psychiatry. (American Psychiatric Assoc., Circulation Dept., 1400 K St., NW, Washington, DC 20005) V.78- 1921- Volume(issue)/page/year: 140,641,1983
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
420 mg/kg
SEX/DURATION :
female 17-22 day(s) after conception lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain)
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,567,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
210 mg/kg
SEX/DURATION :
female 9-15 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 2,69,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
105 mg/kg
SEX/DURATION :
female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Newborn - stillbirth
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 2,69,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
210 mg/kg
SEX/DURATION :
female 7-13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus)
REFERENCE :
JZKEDZ Jitchuken Zenrinsho Kenkyuho. Central Institute for Experimental Animals, Research Reports. (Jikken Dobutsu Chuo Kenkyusho, 1433 Nogawa, Takatsu-ku, Kawasaki 211, Japan) V.1- 1975- Volume(issue)/page/year: 2,69,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
32500 ug/kg
SEX/DURATION :
female 6-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 15,555,1978 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X4986 No. of Facilities: 58 (estimated) No. of Industries: 1 No. of Occupations: 1 No. of Employees: 1657 (estimated) No. of Female Employees: 895 (estimated)
毒理学数据:

1 。
试验方法:口服
摄入剂量: 63 mg/kg/6W-I
测试对象:人-女人
毒性类型:急性
毒性作用: 1.一般麻醉
2.惊厥或癫痫阈值的影响
3.肾,输尿管,膀胱-尿失禁
2 。
试验方法:口服
摄入剂量: 391 mg/kg/1Y-I
测试对象:人-人
毒性类型:急性
毒性作用: 1.惊厥或癫痫阈值的影响
2.肾,输尿管,膀胱-尿失禁

3 。
试验方法:口服
摄入剂量: 20毫克/千克
测试对象:人-女人
毒性类型:急性
毒性作用: 1.惊厥或癫痫阈值的影响
2.心律失常(包括变化的传导)
3.脉搏增加,血压不下降

生态数据:

该物质对环境可能有危害,对水体应给予特别注意。

盐酸马普替林 MSDS

    马替普林盐酸盐      修改号码:5.3    

模块 1. 化学品
    产品名称:      Maprotiline Hydrochloride    
    修改号码:      5.3    

模块 2. 危险性概述
  GHS分类
     物理性危害        未分类    
     健康危害
    急性毒性(经口)      第4级    
     环境危害        未分类    
  GHS标签元素
     图标或危害标志
     信号词        警告    
     危险描述        吞咽有害。    
     防范说明
  [预防]        使用本产品时切勿吃东西,喝水或吸烟。    
    处理后要彻底清洗双手。
  [急救措施]      食入:若感不适,呼叫解毒中心/医生。漱口。    
  [废弃处置]      根据当地政府规定把物品/容器交与工业废弃处理机构。    

模块 3. 成分/组成信息
  单一物质/混和物        单一物质    
  化学名(中文名):        马替普林盐酸盐    
    百分比:      >98.0%(HPLC)(T)    
  CAS编码:      10347-81-6    
    俗名:      9-(γ-Methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene Hydrochloride    
    分子式:      C20H23N·HCl    

模块 4. 急救措施
    吸入:      将受害者移到新鲜空气处,保持呼吸通畅,休息。若感不适请求医/就诊。    
    马替普林盐酸盐      修改号码:5.3    

模块 4. 急救措施
    皮肤接触:      立即去除/脱掉所有被污染的衣物。用水清洗皮肤/淋浴。    
  若皮肤刺激或发生皮疹:求医/就诊。
    眼睛接触:        用水小心清洗几分钟。如果方便,易操作,摘除隐形眼镜。继续清洗。    
  如果眼睛刺激:求医/就诊。
    食入:      若感不适,呼叫解毒中心/医生。漱口。    
    紧急救助者的防护:        救援者需要穿戴个人防护用品,比如橡胶手套和气密性护目镜。    

模块 5. 消防措施
    合适的灭火剂:        干粉,泡沫,雾状水,二氧化碳    
    特殊危险性:        小心,燃烧或高温下可能分解产生毒烟。    
    特定方法:        从上风处灭火,根据周围环境选择合适的灭火方法。    
    非相关人员应该撤离至安全地方。
    周围一旦着火:如果安全,移去可移动容器。
    消防员的特殊防护用具:        灭火时,一定要穿戴个人防护用品。    

模块 6. 泄漏应急处理
    个人防护措施,防护用具,      使用个人防护用品。远离溢出物/泄露处并处在上风处。    
    紧急措施:        泄露区应该用安全带等圈起来,控制非相关人员进入。    
    环保措施:        防止进入下水道。    
    控制和清洗的方法和材料:        清扫收集粉尘,封入密闭容器。注意切勿分散。附着物或收集物应该立即根据合适的    
    法律法规处置。

模块 7. 操作处置与储存
    处理
    技术措施:        在通风良好处进行处理。穿戴合适的防护用具。防止粉尘扩散。处理后彻底清洗双手    
    和脸。
    注意事项:        如果粉尘或浮质产生,使用局部排气。    
    操作处置注意事项:        避免接触皮肤、眼睛和衣物。    
    贮存
    储存条件:        保持容器密闭。存放于凉爽、阴暗处。    
    远离不相容的材料比如氧化剂存放。
    包装材料:        依据法律。    

模块 8. 接触控制和个体防护
    工程控制:        尽可能安装封闭体系或局部排风系统,操作人员切勿直接接触。同时安装淋浴器和洗    
    眼器。
    个人防护用品
     呼吸系统防护:        防尘面具。依据当地和政府法规。    
     手部防护:        防护手套。    
     眼睛防护:        安全防护镜。如果情况需要,佩戴面具。    
     皮肤和身体防护:        防护服。如果情况需要,穿戴防护靴。    

模块 9. 理化特性
    固体
  外形(20°C):
    外观:      晶体-粉末    
    颜色:        白色类白色    
    气味:        无资料    
  pH:        无数据资料    
    熔点:      242°C    
    马替普林盐酸盐      修改号码:5.3    

模块 9. 理化特性
  沸点/沸程        无资料    
    闪点:        无资料    
    爆炸特性
     爆炸下限:        无资料    
     爆炸上限:        无资料    
    密度:        无资料    
    溶解度:
  [水]        极微溶于    
  [其他溶剂]
    溶于:        甲醇    
    微溶于:        乙醇    
  log水分配系数 =      2    

模块 10. 稳定性和反应性
    化学稳定性:        一般情况下稳定。    
    危险反应的可能性:        未报道特殊反应性。    
    须避免接触的物质        氧化剂    
  危险的分解产物:      一氧化碳, 二氧化碳, 氮氧化物 (NOx), 氯化氢    

模块 11. 毒理学信息
    急性毒性:      orl-rat LD50:760 mg/kg    
  ipr-rat LD50:72 mg/kg
  ivn-rat LD50:35 mg/kg
  scu-rat LD50:170 mg/kg
  orl-wmn LDLo:90 mg/kg
    对皮肤腐蚀或刺激:        无资料    
    对眼睛严重损害或刺激:        无资料    
    生殖细胞变异原性:        无资料    
    致癌性:
  IARC =        无资料    
  NTP =        无资料    
    生殖毒性:        无资料    
  RTECS 号码:      KJ4555000    

模块 12. 生态学信息
    生态毒性:
    鱼类:        无资料    
    甲壳类:        无资料    
    藻类:        无资料    
  残留性 / 降解性:        无资料    
  潜在生物累积 (BCF):        无资料    
    土壤中移动性
   log水分配系数:      2    
   土壤吸收系数 (Koc):        无资料    
     亨利定律        无资料    
  constant(PaM3/mol):

模块 13. 废弃处置
    如果可能,回收处理。请咨询当地管理部门。建议在可燃溶剂中溶解混合,在装有后燃和洗涤装置的化学焚烧炉中
    焚烧。废弃处置时请遵守国家、地区和当地的所有法规。
    马替普林盐酸盐      修改号码:5.3    

模块 14. 运输信息
    联合国分类:        与联合国分类标准不一致    
  UN编号:        未列明    

模块 15. 法规信息
  《危险化学品安全管理条例》(2002年1月26日国务院发布,2011年2月16日修订): 针对危险化学品的安全使用、
    生产、储存、运输、装卸等方面均作了相应的规定。


模块16 - 其他信息
N/A

盐酸马普替林 海关数据

中国海关编码:2921499090

概述:
2921499090 其他芳香单胺及衍生物及它们的盐. 增值税率:17.0% 退税率:9.0% 监管条件:无 最惠国关税:6.5% 普通关税:30.0%
申报要素:
品名, 成分含量, 用途
摘要/Summary:
2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0%

盐酸马普替林 分子结构与计算化学数据

分子结构数据

1、摩尔折射率:无可用的

2、摩尔体积(cm3/mol):无可用的

3、等张比容(90.2K):无可用的

4、表面张力(dyne/cm):无可用的

5、介电常数:无可用的

6、极化率(10-24cm3):无可用的

7、单一同位素质量:313.159727 Da

8、标称质量:313 Da

9、平均质量:313.8643 Da

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:2

3.氢键受体数量:1

4.可旋转化学键数量:4

5.互变异构体数量:无

6.拓扑分子极性表面积12

7.重原子数量:22

8.表面电荷:0

9.复杂度:339

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:2

盐酸马普替林 下游产品

推荐供应商更多供应商>>

湖北魏氏化学试剂股份有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度:99% 包装信息:100g,500g,1kg,5kg,25kg 价格:0.0元 - 14,000.0元
联系方式:
联系人:张经理 电话:027-59102966 手机:18717199209

上海吉至生化科技有限公司

产品介绍:
产品名称:马替普林盐酸盐 Cas号:10347-81-6 纯度:>98.0%(HPLC)(T) 包装信息:1gea,200mgea,25gea,5gea 价格:38.0元 - 2,008.0元
联系方式:
联系人:江珊 电话:021-57520831 手机:15316869680

湖北鑫鸣泰化学有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度:98% 包装信息:25/桶kg 价格:1.0元
联系方式:
联系人:黄经理 电话:027-51833411 手机:13237166274

湖北江民泰华化工有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度:99% 包装信息:200kg,25kg 价格:洽谈
联系方式:
联系人:张经理 电话:13396038321 手机:13396038321

湖北恩星生物科技有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度: 包装信息:100kg,200kg,300kg,400kg,500kg 价格:64.0元 - 100.0元
联系方式:
联系人:邵经理 电话:16621771607 手机:16621771607

武汉琼格生物科技有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度:0.99 包装信息:200mg,200mg,200mg,200mg,200mg 价格:37.0元 - 37.0元
联系方式:
联系人:时燕 电话:027-84235681 手机:13657207535

湖北众善奉行医药科技有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度:98 包装信息:100g 价格:洽谈
联系方式:
联系人:张丽 电话:027-61907345 手机:13397111514

武汉市维斯尔曼生物工程有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度:99% 包装信息:25kg,1kg,100g,10g,1g 价格:1.0元 - 1.0元
联系方式:
联系人:王明 电话:027-59402396 手机:13419635609

武汉云秀医药技术有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度:99% 包装信息:1kg 价格:1.0元
联系方式:
联系人:路 电话:027-51239964 手机:13437116195

斯百全化学(上海)有限公司

产品介绍:
产品名称:盐酸马普替林 Cas号:10347-81-6 纯度: 包装信息:洽谈 价格:洽谈
联系方式:
联系人:spectrum china sales 电话:021-67601398 手机:18616765336